一种新型的吡唑并[1,5- a ]嘧啶在C(3)处带有3-羟基苯基,在C(7)处具有取代的托烷类被确定为有效的B-Raf抑制剂。探索替代的官能团,以取代C(3)酚证明吲唑是有效的等排物。几种具有取代的吲唑残基的化合物(例如4e,4p和4r)在亚微摩尔浓度下可有效抑制A375和WM266细胞系中的细胞增殖,后两种化合物在细胞中也表现出良好的治疗指数。
Bridged, Bicyclic Heterocyclic or Spiro Bicyclic Heterocyclic Derivatives of Pyrazolo[1, 5-A]Pyrimidines, Methods for Preparation and Uses Thereof
申请人:Levin Jeremy Ian
公开号:US20100029657A1
公开(公告)日:2010-02-04
Compounds of formula A:
and pharmaceutically acceptable salts thereof are described, which selectively inhibit Raf kinase activity and are useful for treating disorders mediated by Raf kinases.
[EN] BRIDGED, BICYCLIC HETEROCYCLIC OR SPIRO BICYCLIC HETEROCYCLIC DERIVATIVES OF PYRAZOLO[1,5-A]PYRIMIDINES, METHODS FOR PREPARATION AND USES THEREOF<br/>[FR] DÉRIVÉS HÉTÉROCYCLIQUES BICYCLIQUES PONTÉS OU HÉTÉROCYCLIQUES BICYCLIQUES SPIRO DE PYRAZOLO[1,5-A]PYRIMIDINES, LEURS PROCÉDÉS DE PRÉPARATION ET LEURS UTILISATIONS
申请人:WYETH CORP
公开号:WO2009108838A8
公开(公告)日:2009-11-12
BRIDGED, BICYCLIC HETEROCYCLIC OR SPIRO BICYCLIC HETEROCYCLIC DERIVATIVES OF PYRAZOLO[1,5-A]PYRIMIDINES, METHODS FOR PREPARATION AND USES THEREOF